18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) as early imaging biomarker of axillary sentinel lymph node (SLN) status in locally advanced node-positive breast cancer (NPBC) patients (pts) receiving neoadjuvant chemotherapy (NACT)

被引:0
|
作者
Dockx, Yanina
Huizing, Manon Thirza
Van den Wyngaert, Tim
Altintas, Sevilay
Huyghe, Ivan
Geboers, Inge
Vervliet, Johan
Molderez, Christoph
van Goethem, Mireille
van Marck, Veerle
Sonnemans, Hetty
Tjalma, Wiebren
机构
[1] Univ Antwerp Hosp, Edegem, Belgium
[2] AZ ST Dimpna Geel, Geel, Belgium
[3] AZ ST Dimpna Geel, Geel, Belgium
[4] Univ Antwerp Hosp, Antwerp, Belgium
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1129
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging—initial findings
    Tadeusz W. Stadnik
    Hendrik Everaert
    Smitha Makkat
    Robert Sacré
    Jan Lamote
    Claire Bourgain
    European Radiology, 2006, 16 : 2153 - 2160
  • [32] The prognostic role of baseline 18F-FDG PET/CT SUVmax and SUVmax change in patients with node-positive breast cancer receiving neoadjuvant chemotherapy
    Can, Canan
    Akdeniz, Nadiye
    Komek, Halil
    Gundogan, Cihan
    Urakci, Zuhat
    Isikdogan, Abdurrahman
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2022, 41 (01): : 3 - 10
  • [33] The distribution of axillary lymph nodes metastases and sentinel node biopsy after neoadjuvant chemotherapy in patients with locally advanced breast cancer
    Li, J.
    Wang, L.
    Liu, Y.
    Zhao, T.
    EJC SUPPLEMENTS, 2008, 6 (07): : 154 - 155
  • [34] The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography
    Park, Jeong Seon
    Moon, Woo Kyung
    Lyou, Chae Yeon
    Cho, Nariya
    Kang, Keon Wook
    Chung, June-Key
    ACTA RADIOLOGICA, 2011, 52 (01) : 21 - 28
  • [35] USE OF 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY (FDG PET/CT) TO PREDICT VIABLE LYMPH NODE METASTASES FOLLOWING PREOPERATIVE CHEMOTHERAPY FOR MUSCLE INVASIVE AND ADVANCED-STAGE BLADDER CANCER
    Lee, Byron
    Bagrodia, Aditya
    Donahue, Timothy
    Dalbagni, Guido
    Rosenberg, Jonathan
    Bajorin, Dean
    Vargas, Hebert Alberto
    Bochner, Bernard
    JOURNAL OF UROLOGY, 2015, 193 (04): : E125 - E125
  • [36] Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer
    Barranger, E
    Grahek, D
    Antoine, M
    Montravers, F
    Talbot, JN
    Uzan, S
    ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (06) : 622 - 627
  • [37] Evaluation of Fluorodeoxyglucose Positron Emission Tomography in the Detection of Axillary Lymph Node Metastases in Patients With Early-Stage Breast Cancer
    Emmanuel Barranger
    Dany Grahek
    Martine Antoine
    Françoise Montravers
    Jean-Noel Talbot
    Serge Uzan
    Annals of Surgical Oncology, 2003, 10 : 622 - 627
  • [38] Utilization of sentinel lymph node mapping to determine pathologic outcomes for patients receiving neoadjuvant chemotherapy for locally advanced breast cancer
    Bland, KI
    ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (03) : 217 - 219
  • [39] Utilization of sentinel lymph node mapping to determine pathologic outcomes for patients receiving neoadjuvant chemotherapy for locally advanced breast cancer
    Kirby I. Bland
    Annals of Surgical Oncology, 2002, 9 (3) : 217 - 219
  • [40] Diagnostic Value of Dynamic 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (18F-FDG PET-CT) in Cervical Lymph Node Metastasis of Nasopharyngeal Cancer
    Li, Guanglie
    Yang, Shuai
    Wang, Siyang
    Jiang, Renwei
    Xu, Xiwei
    DIAGNOSTICS, 2023, 13 (15)